收费全文 | 1973846篇 |
免费 | 147745篇 |
国内免费 | 3552篇 |
耳鼻咽喉 | 29006篇 |
儿科学 | 62552篇 |
妇产科学 | 58141篇 |
基础医学 | 286811篇 |
口腔科学 | 56575篇 |
临床医学 | 170162篇 |
内科学 | 380815篇 |
皮肤病学 | 40422篇 |
神经病学 | 156125篇 |
特种医学 | 77623篇 |
外国民族医学 | 524篇 |
外科学 | 306610篇 |
综合类 | 47121篇 |
现状与发展 | 3篇 |
一般理论 | 539篇 |
预防医学 | 148746篇 |
眼科学 | 46261篇 |
药学 | 149869篇 |
1篇 | |
中国医学 | 3769篇 |
肿瘤学 | 103468篇 |
2018年 | 17884篇 |
2015年 | 17967篇 |
2014年 | 25157篇 |
2013年 | 38473篇 |
2012年 | 52473篇 |
2011年 | 55861篇 |
2010年 | 32809篇 |
2009年 | 30925篇 |
2008年 | 53697篇 |
2007年 | 58367篇 |
2006年 | 58618篇 |
2005年 | 57805篇 |
2004年 | 55965篇 |
2003年 | 54165篇 |
2002年 | 52876篇 |
2001年 | 85023篇 |
2000年 | 87256篇 |
1999年 | 74225篇 |
1998年 | 21749篇 |
1997年 | 19698篇 |
1996年 | 19753篇 |
1995年 | 18679篇 |
1994年 | 17792篇 |
1993年 | 16519篇 |
1992年 | 61363篇 |
1991年 | 60431篇 |
1990年 | 59475篇 |
1989年 | 57740篇 |
1988年 | 53885篇 |
1987年 | 52993篇 |
1986年 | 50598篇 |
1985年 | 48551篇 |
1984年 | 36888篇 |
1983年 | 31919篇 |
1982年 | 19502篇 |
1981年 | 17575篇 |
1980年 | 16357篇 |
1979年 | 35985篇 |
1978年 | 25607篇 |
1977年 | 21831篇 |
1976年 | 20471篇 |
1975年 | 22321篇 |
1974年 | 26934篇 |
1973年 | 26025篇 |
1972年 | 24713篇 |
1971年 | 22920篇 |
1970年 | 21607篇 |
1969年 | 20879篇 |
1968年 | 19353篇 |
1967年 | 17354篇 |
Background
One daily dose of tacrolimus (QDT) improves adherence in kidney transplant (KT) recipients. A switch from twice-daily tacrolimus (BDT) to QDT showed similar efficacy and safety.Methods
The aim of our study was to demonstrate the long-term efficacy and safety of switching from BDT to QDT in KT recipients. Preliminary results have already been published. Forty-one patients (34 men and 7 women), mean age at KT of 43.9 ± 12.7 years, underwent a 1:1 dose switch from BDT to QDT; the mean time from KT to switch was 36.6 ± 16.1 months. In our study population, 4 patients received a living donor KT and 2 received a second allograft.Results
The mean follow-up was 86.8 ± 13 months from the switch and 126.2 ± 22.3 months from KT. Graft and patient survival rates were 90.2% and 95.1%, respectively. All patients maintained stable renal function during follow-up. During the first 3 months after the switch we observed a significant decrease in tacrolimus blood level (P = .0001). No significant differences were observed regarding tacrolimus dose before and after QDT introduction (P = not significant [NS]). Fourteen patients who stopped steroids under BDT treatment and 16 patients who stopped steroids after the switch are currently steroid-free.Conclusion
Our study showed safety and efficacy in switching from BDT to QDT. After early (<1 year) dose adjustment, tacrolimus blood levels remained stable throughout follow-up. Moreover, QDT represented a valid alternative for patients showing steroid side effects. 相似文献Robotic approaches have been steadily replacing laparoscopic approaches in metabolic and bariatric surgeries (MBS); however, their superiority has not been rigorously evaluated. The main goal of the study was to evaluate the 5-year utilization trends of robotic MBS and to compare to laparoscopic outcomes.
MethodsRetrospective analysis of 2015–2019 MBSAQIP data. Kruskal-Wallis test/Wilcoxon and Fisher’s exact/chi-square were used to compare continuous and categorical variables, respectively. Generalized linear models were used to compare surgery outcomes.
ResultsThe use of robotic MBS increased from 6.2% in 2015 to 13.5% in 2019 (N= 775,258). Robotic MBS patients had significantly higher age, BMI, and likelihood of 12 diseases compared to laparoscopic patients. After adjustment, robotic MBS patients showed higher 30-day interventions and 30-day readmissions alongside longer surgery time (26–38 min).
ConclusionRobotic MBS shows higher intervention and readmission even after controlling for cofounding variables.
Graphical Abstract 相似文献